APOBEC3B and neoplasm: Specifically, full body expression of CAG promoter-driven levels of human A3B, which approximate those reported in many human tumors, results in accelerated rates of B-cell lymphomagenesis and hepatocellular carcinogenesis as well as a smaller number of other tumor types.